Helixgate https://validator.w3.org/feed/docs/rss2.html Adaptyv Bio reveals latest results in protein design competition Predicting consequences of new hepatitis B vaccine recs Novartis’ sales dip as generics pressure intensifies, radioequivalents loom Lilly strikes second partnership this year for recombinase-based gene editing Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead. Big Pharma–backed Coultreon bags $125M series A to unlock alternative immune pathway Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up Opinion: Why do discussions about ‘brain health’ ignore mental illness? Garijo starts as Sanofi CEO with window to ease reliance on Dupixent Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts, but no deals in the works Heritable immunization of mice against Lyme disease enables ecological disease prevention Home Retron-Powered Approach Enables Genome Editing Across Diverse Bacterial Species New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy Erasca reports RAS cancer drug data after legal threat from Revolution Sun Pharma Aims for Top 3 in Women’s Health with $11.75B Organon Purchase Dems say RFK Jr. has a pattern of failing to answer their questions Revolution Medicines threatens to sue Erasca over patent, efficacy claims Trump administration warns against using federal dollars on fentanyl test strips Utah doctors demand suspension of Doctronic AI program Anticancer Strategy Targets Defense Mechanism in Senescent Cells Oruka surges as long-acting psoriasis drug shows early promise The structural data bottleneck in AI antibody discovery Q&A: Intellia CEO talks first Phase 3 CRISPR readout and what’s next Thermo Fisher sells microbiology biz; Ligand to buy XOMA Monoclonal Antibodies: Unlocking Cost and Efficiency Gains in Downstream Processing Compass shares crash as ‘confounding’ survival data raise approvability questions for bispecific STAT+: An insider reveals the real goals of prior authorization Sun Pharma beams up Organon in $11.75B acquisition Oruka posts Phase 2 win in psoriasis, hoping to compete with Skyrizi Genetic Medicine Delivery Enhanced by Producer Cell Modifications STAT+: Astellas retries XLMTM gene therapy after deaths Lilly lands third oncology deal in 3 weeks, inking up to $2.3B for Ajax Intellia heads to FDA after notching first late-stage win for in vivo gene editor Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitor UCSF, Par Health hit with FDA warning letters for environmental monitoring issues Seaport, Hemab chart courses for $180M IPOs to fund depression, clotting candidates Compass Therapeutics unveils key secondary endpoint results from pivotal biliary tract cancer trial Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial Veradermics wins at growing hair with oral Rogaine in first key test as a public company J&J puts blockbuster blood thinner Xarelto on TrumpRx STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depression Abdominal Contractions May Drive Brain Fluid Flow, Aiding in Neural Waste Clearance What happened to Covid? Sun Pharma to buy Organon for $11.75B in major portfolio expansion Turn health data into impact: Browns University’s online master in biostatistics & health data science Gene therapy leaders aim to help more Baby KJs with novel regulatory models Improving metagenome binning by integrating intrinsic features and taxonomy